These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 10333138)

  • 1. New developments in the epidemiology, natural history and management of genital herpes.
    Stanberry L; Cunningham A; Mertz G; Mindel A; Peters B; Reitano M; Sacks S; Wald A; Wassilew S; Woolley P
    Antiviral Res; 1999 May; 42(1):1-14. PubMed ID: 10333138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reducing the risk of transmitting genital herpes: advances in understanding and therapy.
    Leone P
    Curr Med Res Opin; 2005 Oct; 21(10):1577-82. PubMed ID: 16238897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genital herpes infection: a review.
    Brugha R; Keersmaekers K; Renton A; Meheus A
    Int J Epidemiol; 1997 Aug; 26(4):698-709. PubMed ID: 9279600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An international, randomized, double-blind, placebo-controlled, study of valacyclovir for the suppression of herpes simplex virus type 2 genital herpes in newly diagnosed patients.
    Fife KH; Warren TJ; Justus SE; Heitman CK;
    Sex Transm Dis; 2008 Jul; 35(7):668-73. PubMed ID: 18461016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An update on short-course episodic and prevention therapies for herpes genitalis.
    Corey L; Bodsworth N; Mindel A; Patel R; Schacker T; Stanberry L
    Herpes; 2007 Jun; 14 Suppl 1():5A-11A. PubMed ID: 17877886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of daily valacyclovir suppression on herpes simplex virus type 2 viral shedding in HSV-2 seropositive subjects without a history of genital herpes.
    Sperling RS; Fife KH; Warren TJ; Dix LP; Brennan CA
    Sex Transm Dis; 2008 Mar; 35(3):286-90. PubMed ID: 18157071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does frequency of genital herpes recurrences predict risk of transmission? Further analysis of the valacyclovir transmission study.
    Kim HN; Wald A; Harris J; Almekinder J; Heitman C; Corey L
    Sex Transm Dis; 2008 Feb; 35(2):124-8. PubMed ID: 17921912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on antiviral therapy for genital herpes infection.
    Geers TA; Isada CM
    Cleve Clin J Med; 2000 Aug; 67(8):567-73. PubMed ID: 10946451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Famciclovir reduces viral mucosal shedding in HSV-seropositive persons.
    Leone P; Warren T; Hamed K; Fife K; Wald A
    Sex Transm Dis; 2007 Nov; 34(11):900-7. PubMed ID: 17538513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of genital herpes.
    Mertz GJ
    Adv Exp Med Biol; 1996; 394():1-10. PubMed ID: 8815676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valacyclovir for the treatment of genital herpes.
    Brantley JS; Hicks L; Sra K; Tyring SK
    Expert Rev Anti Infect Ther; 2006 Jun; 4(3):367-76. PubMed ID: 16771614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Once-daily valacyclovir to reduce the risk of transmission of genital herpes.
    Corey L; Wald A; Patel R; Sacks SL; Tyring SK; Warren T; Douglas JM; Paavonen J; Morrow RA; Beutner KR; Stratchounsky LS; Mertz G; Keene ON; Watson HA; Tait D; Vargas-Cortes M;
    N Engl J Med; 2004 Jan; 350(1):11-20. PubMed ID: 14702423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of valacyclovir on viral shedding in immunocompetent patients with recurrent herpes simplex virus 2 genital herpes: a US-based randomized, double-blind, placebo-controlled clinical trial.
    Fife KH; Warren TJ; Ferrera RD; Young DG; Justus SE; Heitman CK; Burroughs SM
    Mayo Clin Proc; 2006 Oct; 81(10):1321-7. PubMed ID: 17036557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Genital herpes: epidemiology, transmission, clinic, asymptomatic viral excretion, impact on other sexually transmitted diseases, prevention, and treatment].
    Bossi P
    Ann Dermatol Venereol; 2002 Apr; 129(4 Pt 2):477-93. PubMed ID: 12122319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving the management of genital herpes.
    Sacks SL
    Hosp Pract (1995); 1999 Feb; 34(2):41-9; quiz 139. PubMed ID: 10047759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative efficacy of famciclovir and valacyclovir for suppression of recurrent genital herpes and viral shedding.
    Wald A; Selke S; Warren T; Aoki FY; Sacks S; Diaz-Mitoma F; Corey L
    Sex Transm Dis; 2006 Sep; 33(9):529-33. PubMed ID: 16540883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress in meeting today's demands in genital herpes: an overview of current management.
    Patel R
    J Infect Dis; 2002 Oct; 186 Suppl 1():S47-56. PubMed ID: 12353187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genital herpes: antiviral therapy for symptom relief and prevention of transmission.
    Gupta R; Wald A
    Expert Opin Pharmacother; 2006 Apr; 7(6):665-75. PubMed ID: 16556084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One-day regimen of valacyclovir for treatment of recurrent genital herpes simplex virus 2 infection.
    Bavaro JB; Drolette L; Koelle DM; Almekinder J; Warren T; Tyring S; Wald A
    Sex Transm Dis; 2008 Apr; 35(4):383-6. PubMed ID: 18362859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of antiviral therapy for herpes labialis, genital herpes and herpes zoster.
    Moomaw MD; Cornea P; Rathbun RC; Wendel KA
    Expert Rev Anti Infect Ther; 2003 Aug; 1(2):283-95. PubMed ID: 15482124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.